[Tyr0]-C-Peptide (Human)

CAS : 57327-90-9

Ref. 3D-PCP-3724-PI

Informations sur le produit

• Nom: [Tyr0]-C-Peptide (Human)
• Synonymes: ProinsulinC-peptide (human), N-L-tyrosyl-, Proinsulin connecting peptide (human),1-de-L-arginine-2-L-tyrosine-34-de-L-lysine-35-de-L-arginine-, 304: PN: US20090175821 SEQID: 378claimed protein, Proinsulin C-peptide [tyrosyl] (human), L-Glutamine,L-tyrosyl-L-a-glutamyl-L-alanyl-L-a-glutamyl-L-a-aspartyl-L-leucyl-L-glutaminyl-L-valylglycyl-L-glutaminyl-L-valyl-L-a-glutamyl-L-leucylglycylglycylglycyl-L-prolylglycyl-L-alanylglycyl-L-seryl-L-leucyl-L-glutaminyl-L-prolyl-L-leucyl-L-alanyl-L
• CAS: 57327-90-9

Description

This product is a C-peptide derivative for use in radioimmunoassays. C-peptide is a peptide hormone that is cleaved from proinsulin in the pancreatic beta cells. During glycaemia C-peptide alongside insulin are released by the beta cells. Interestingly C-peptide is not immediately metabolised by the liver and it also has a relatively long half life compared to insulin. Therefore it can be a useful biomarker to monitor beta cell function. Increased levels of C-peptide occurring in patients with insulin resistant type 2 diabetes mellitus, have been associated with macrovascular complications and cardiovascular morbidity. Furthermore C-peptide has been found to prevent endothelial cell reactive oxygen species from being formed thus reducing oxidative stress. This also may lead to anti-inflammatory and anti-apoptotic responses.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 3,183.5 g/mol
• Formule: C₁₃₈H₂₂₀N₃₆O₅₀
• Degré de pureté: Min. 95%